Unlocking the Hidden Effects of Shockwave: Longitudinal Changes in Sensorimotor Function and Kinesiophobia in Adolescents With Patellar Tendinopathy

N/AActive Not RecruitingNCT07797764

Ahmed Alshimy50 enrolled

Overview

Patellar tendinopathy (PT) is a commonly used term for the clinical manifestation of patellar tendon pain and functional limitation with multifactorial etiology. It occurs in both athletes and general population in all age groups. It is often characterized as an overuse injury resulting from chronic failure of the healing response that is not strictly linked to inflammatory or degenerative processes.

Once enrolled, participants were examined by a physiotherapist, and received the first application of ESWT (week 0). At weekly intervals, they received three more applications and on the day of the last application (week 3), a control clinical examination was performed. In the 12th-week follow-up after the last application week 15), a final examination including joint position sense, balance and kinesiophobia evaluation was performed.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Patellar Tendinopathy

Interventions

Extracorporeal Shockwave TherapyDEVICE

The low-energy focused ESWT was applied using the BTL-6000 FSWT device with piezoelectric generator and a coupling pad which modulates penetration depth to 0-35 mm. The setting was chosen based on ISMST guidelines (https://shockwavether apy.org). Energy flux density varied between 0.14 and 0.18 mJ/ mm2 due to patient tolerance, frequency was set at 8 Hz. A total of 2000 shocks were applied semi-statically to the most defined pathological area in the patellar tendon followed by2000 shocks dynamically to the quadriceps muscle.

Eligibility

Sex: ALLMin age: 15 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Has patellar tendon pain, which limits (at least in part) the quality of normal daily. * Has clinical manifestation of PT (pain and impaired function) confirmed by a clinician. * Has symptoms only in one leg, the other one is asymptomatic. * Normal BMI. Exclusion Criteria: * Any contraindication for ESWT is present (according to the International Society for Medical Shockwave Treatment \[ISMST\] consensus at https://shockwavetherapy.org). * They were aware of any symptomatic mechanical tendon damage in the past (e.g. partial or complete rupture in relation to the injury), neurological, oncological, or systemic disease (e.g. neuropathy, lupus or rheumatic arthritis) coexists * They were already treated for PT elsewhere up to 3 months prior to the study (e.g. platelet- rich plasma therapy, physiotherapy incl. resistance training or ESWT).

Locations (1)

Al Ryada University for Science and Technology

Sadat, Menoufia, Egypt

Outcomes

Primary Outcomes

Digital inclinometer

Time frame: 4 months

Tampa scale for Kinesiophobia

Time frame: 4 months

Biodex balance system (overall stability index)

Time frame: 4 months

Biodex balance system (Anteroposterior)

Time frame: 4 months

Biodex balance system (Mediolateral)

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.